Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Minority Interest (2016 - 2017)

IGC Pharma (IGC) has disclosed Minority Interest for 7 consecutive years, with -$9007.0 as the latest value for Q4 2017.

  • Quarterly Minority Interest changed 0.08% to -$9007.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$9007.0 through Dec 2017, changed 0.08% year-over-year, with the annual reading at -$8836.0 for FY2017, 101.87% down from the prior year.
  • Minority Interest for Q4 2017 was -$9007.0 at IGC Pharma, down from -$8854.0 in the prior quarter.
  • The five-year high for Minority Interest was $576803.0 in Q2 2014, with the low at -$9007.0 in Q4 2017.
  • Average Minority Interest over 5 years is $393083.6, with a median of $523033.0 recorded in 2014.
  • The sharpest move saw Minority Interest rose 6.96% in 2014, then tumbled 102.1% in 2017.
  • Over 5 years, Minority Interest stood at $531772.0 in 2013, then rose by 4.67% to $556612.0 in 2014, then increased by 2.35% to $569702.0 in 2015, then plummeted by 101.58% to -$9000.0 in 2016, then decreased by 0.08% to -$9007.0 in 2017.
  • According to Business Quant data, Minority Interest over the past three periods came in at -$9007.0, -$8854.0, and -$8790.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.